Parcourir par auteur "Liaskos, C."
Voici les éléments 1-20 de 59
-
Adiponectin: A New Independent Predictor of Liver Steatosis and Response to IFN-alpha Treatment in Chronic Hepatitis C
Zografos, T. A.; Liaskos, C.; Rigopoulou, E. I.; Togousidis, E.; Makaritsis, K.; Germenis, A.; Dalekos, G. N. (2008)OBJECTIVES: To compare serum adiponectin and tumor necrosis factor (TNF)-alpha among patients with viral liver diseases; to investigate associations of serum adiponectin and TNF-alpha with histological or viral characteristics ... -
Alterations of leptin during IFN-alpha therapy in patients with chronic viral hepatitis
Zografos, T. A.; Rigopoulou, E. I.; Liaskos, C.; Togousidis, E.; Zachou, K.; Gatselis, N.; Germenis, A.; Dalekos, G. N. (2006)Background/Aims: Leptin has a particular profibrogenic role in the liver. We investigated whether IFN-alpha influences leptin production in patients with chronic hepatitis B (CHB) and C (CHC). Leptin was determined in ... -
Anti-cardiolipin antibodies (anti-CL) in patients with hepatitis C virus (HCV) infection are independent of beta2-glycoprotein I (b2GPI) co-factor or features of antiphospholipid syndrome (APS)
Zachou, K.; Liaskos, C.; Christodoulou, D.; Kardasi, M.; Papadamou, G.; Gatselis, N.; Gerovasilis, F.; Tsianos, E.; Dalekos, G. (2002) -
Anti-cardiolipin antibodies in patients with chronic viral hepatitis are independent of beta2-glycoprotein I cofactor or features of antiphospholipid syndrome
Zachou, K.; Liaskos, C.; Christodoulou, D. K.; Kardasi, M.; Papadamou, G.; Gatselis, N.; Georgiadou, S. P.; Tsianos, E. V.; Dalekos, G. N. (2003)Background Although controversial, some authorities have implicated hepatitis C virus (HCV) as a cause of anti-phospholipid syndrome (APLS). Anti-cardiolipin antibodies (anti-CLAbs) in APLS are cofactor-dependent ('pathogenic' ... -
Anti-gp210 antibody mirrors disease severity in primary biliary cirrhosis
Bogdanos, D. P.; Liaskos, C.; Pares, A.; Norman, G.; Rigopoulou, E. I.; Caballeria, L.; Dalekos, G. N.; Rodes, J.; Vergani, D. (2007) -
ANTI-HELICOBACTER PYLORI ANTIBODY RESPONSE AS A TRIGGER OF PRIMARY BILIARY CIRRHOSIS-SPECIFIC ANTI-MITOCHONDRIAL ANTIBODIES
Koutsoumpas, A.; Polymeros, D.; Liaskos, C.; Mytilinaiou, M.; Dalekos, G. N.; Bogdanos, D. P.; Vergani, D. (2008) -
Anti-mitochondrial antibodies in patients with systemic lupus erythematosus: Revealing the unforeseen
Bogdanos, D. P.; Liaskos, C.; Rigopoulou, E. I.; Dalekos, G. N. (2006) -
Anti-mitochondrial antibody immunofluorescent titres correlate with the number and intensity of immunoblot-detected mitochondrial bands in patients with primary biliary cirrhosis
Rigopoulou, E. I.; Bogdanos, D. P.; Liaskos, C.; Koutsoumpas, A.; Baum, H.; Vergani, D.; Dalekos, G. N. (2007)Background: Primary biliary cirrhosis (PBC)-specific anti-mitochondrial antibodies (AMA), routinely detected by indirect immunofluoresnce, immunofix various mitochondrial antigens by immunoblot (IB). We have investigated ... -
Antibodies to hepatitis E virus among hemodialysis patients: An epidemiological survey in central Greece
Stefanidis, L.; Zerbou, E.; Rizos, C.; Liaskos, C.; Syrganis, C.; Dalekos, G. (2003) -
Antibody responses specific for soluble liver antigen co-occur with RO-52 autoantibodies in patients with autoimmune hepatitis
Liaskos, C.; Bogdanos, D. P.; Rigopoulou, E. I.; Norman, G. L.; Shurns, Z.; Al-Chalabi, T.; Krawitt, E. L.; Mieli-Vergani, G.; Czaja, A. J.; Vergani, D.; Dalekos, G. N. (2007) -
Antimitochondrial antibodies of immunoglobulin G3 subclass are associated with a more severe disease course in primary biliary cirrhosis
Rigopoulou, E. I.; Davies, E. T.; Bogdanos, D. P.; Liaskos, C.; Mytilinaiou, M.; Koukoulis, G. K.; Dalekos, G. N.; Vergani, D. (2007)Background/Aims: Primary biliary cirrhosis (PBC) is characterised by the presence of immunoglobulin (Ig) G antimitochondrial antibodies (AMA), which are routinely detected by indirect immunofluorescence (IFL) using composite ... -
The antiphospholipid syndrome and infection
Dalekos, G. N.; Zachou, K.; Liaskos, C. (2001)Infectious agents have been implicated in the induction of antiphospholipid (aPL) antibodies and the development of the antiphospholipid syndrome (APS). This review focuses on the types of aPL antibodies detected in ... -
Asialoglycoprotein receptor (ASGPR) as target autoantigen in liver autoimmunity: Lost and found
Rigopoulou, E. I.; Roggenbuck, D.; Smyk, D. S.; Liaskos, C.; Mytilinaiou, M. G.; Feist, E.; Conrad, K.; Bogdanos, D. P. (2012)Asialoglycoprotein receptor (ASGPR) has attracted the attention of liver immunologists for many years. This liver-specific lectin was found to be a major B and T cell autoantigenic target in patients with autoimmune liver ... -
Autoimmune hepatitis-specific antibodies against soluble liver antigen and liver cytosol type 1 in patients with chronic viral hepatitis
Rigopoulou, E. I.; Mytilinaiou, M.; Romanidou, O.; Liaskos, C.; Dalekos, G. N. (2007)Background. Non-organ specific autoantibodies are highly prevalent in patients with chronic hepatitis C (HCV). Among them, anti-liver kidney microsomal type 1 (LKM1) antibody - the serological marker of type 2 autoimmune ... -
Autoimmune thyroiditis associated with autoimmune hepatitis
Nobili, V.; Liaskos, C.; Luigi, G.; Guidi, R.; Francalanci, P.; Marcellini, M. (2005) -
Bone marrow findings in patients with autoimmune liver diseases
Tsikrikoni, A.; Rigopoulou, E. I.; Zachou, K.; Liaskos, C.; Kyriakou, D.; Dalekos, G. N. (2008)Background and Aims: We have recently reported quantitative and qualitative differences of the bone marrow (BM) hematopoietic progenitor cells in autoimmune hepatitis type-1 (AIH-1) and primary biliary cirrhosis (PBC). In ... -
Cartilage oligomeric matrix protein (COMP): A novel non-invasive marker for assessing liver cirrhosis and risk of progression to hepatocellular carcinoma
Norman, G. L.; Gatselis, N.; Shums, Z.; Liaskos, C.; Bogdanos, D. P.; Koukoulis, G. K.; Dalekos, G. N. (2014) -
Cartilage oligomeric matrix protein: A novel non-invasive marker for assessing cirrhosis and risk of hepatocellular carcinoma
Norman, G. L.; Gatselis, N. K.; Shums, Z.; Liaskos, C.; Bogdanos, D. P.; Koukoulis, G. K.; Dalekos, G. N. (2015)AIM: To assess serum cartilage oligomeric matrix protein (COMP) as a marker of cirrhosis and risk of progression to hepatocellular carcinoma (HCC). METHODS: A COMP enzyme-linked immunosorbent assay was used to test 187 ... -
Chronic hepatitis C is characterised by an interferon-alpha induced novel autoantibody giving a crescent pattern by indirect immunofluorescence
Liaskos, C.; Bogdanos, D. P.; Gatselis, N.; Horner, D.; Shums, Z.; Murphy, D.; Rigopoulou, E. I.; Smith, H.; Vergani, D.; Norman, G. L.; Dalekos, G. N. (2007) -
Clinical significance of organ- and non-organ-specific autoantibodies on the response to anti-viral treatment of patients with chronic hepatitis C
Gatselis, N. K.; Georgiadou, S. P.; Koukoulis, G. K.; Tassopoulos, N.; Zachou, K.; Liaskos, C.; Hatzakis, A.; Dalekos, G. N. (2006)Background: Development of organ- and non-organ-specific autoantibodies has been reported in hepatitis C virus patients treated with interferon-α plus/minus ribavirin. Aims: To address whether prevalence and the titre of ...